Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Moodys
AstraZeneca
Dow
Johnson and Johnson

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR TAZORAC


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Tazorac

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00145106 ↗ Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed Allergan Phase 4 2002-03-01 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 ↗ Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed Jefferson Medical College of Thomas Jefferson University Phase 4 2002-03-01 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 ↗ Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed Milton S. Hershey Medical Center Phase 4 2002-03-01 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 ↗ Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed New York University School of Medicine Phase 4 2002-03-01 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 ↗ Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed NYU Langone Health Phase 4 2002-03-01 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 ↗ Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed State University of New York - Downstate Medical Center Phase 4 2002-03-01 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Tazorac

Condition Name

Condition Name for Tazorac
Intervention Trials
Acne Vulgaris 11
Plaque Psoriasis 2
Sun-Damaged Skin 1
ACTINIC KERATOSES 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Tazorac
Intervention Trials
Acne Vulgaris 11
Psoriasis 3
Basal Cell Nevus Syndrome 2
Keratosis, Actinic 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Tazorac

Trials by Country

Trials by Country for Tazorac
Location Trials
United States 67
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Tazorac
Location Trials
California 7
Florida 6
Texas 6
Pennsylvania 5
New York 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Tazorac

Clinical Trial Phase

Clinical Trial Phase for Tazorac
Clinical Trial Phase Trials
Phase 4 4
Phase 3 4
Phase 2 8
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Tazorac
Clinical Trial Phase Trials
Completed 19
Recruiting 1
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Tazorac

Sponsor Name

Sponsor Name for Tazorac
Sponsor Trials
Bausch Health Americas, Inc. 3
Valeant Pharmaceuticals International, Inc. 3
National Cancer Institute (NCI) 2
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Tazorac
Sponsor Trials
Industry 23
Other 14
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Johnson and Johnson
Baxter
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.